REQUEST A DEMO
Total
USD $0.00
Search more companies

Gn Neutriceuticals Sdn. Bhd. (Malaysia)

Main Activities: Pharmaceutical and Medicine Manufacturing | Pharmacies and Drug Stores
Full name: Gn Neutriceuticals Sdn. Bhd. Profile Updated: April 23, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Gn Neutriceuticals Sdn. Bhd. is an enterprise in Malaysia, with the main office in Subang Jaya. It operates in the Pharmaceutical and Medicine Manufacturing sector. The company was established on December 18, 2003. In 2024, the company reported a net sales revenue increase of 86.43%. Its total assets grew by 40.73% over the same period. The net profit margin of Gn Neutriceuticals Sdn. Bhd. increased by 21.66% in 2024.

Headquarters
No.17, Jalan Tp3,Sime Uep Industrial Park
Subang Jaya; Selangor; Postal Code: 47620

Contact Details: Purchase the Gn Neutriceuticals Sdn. Bhd. report to view the information.

Website: http://www.gnhealthsolutions.com

Basic Information
Registered Capital:
Purchase the Gn Neutriceuticals Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Gn Neutriceuticals Sdn. Bhd. report to view the information.
Incorporation Date:
December 18, 2003
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
36%
Purchase this report to view the information.
32%
Purchase this report to view the information.
32%
Company Performance
Financial values in the chart are available after Gn Neutriceuticals Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
86.43%
Total Operating Revenue
86.43%
Operating Profit
303.25%
Net Profit/Loss for the Period
393.65%
Total Assets
40.73%
Total Equity
47.25%
Operating Profit Margin
24.33%
Net Profit Margin
21.66%
Return on Equity (ROE)
50.62%
Quick Ratio
0.12%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?